The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> March 18, 2022

Interview with the Co-Founder and CEO: GenSight Biologics SA (OTCMKTS:GSGTF)

Gilly, Bernard
Bernard Gilly, Ph.D., one of GenSight Biologics’ founders, has served as the Chief Executive Officer of the company since its creation. From creation through to 2016, Dr. Gilly served as Chairman of the board of directors. From 2011 through 2014, he served as Chief Executive Officer at Pixium Vision, during which time he also served as non-executive Chairman of the board of directors. In addition, he currently serves on the boards of Prophesee S.A. (formerly Chronocam) and TISSIUM (formerly Gecko Biomedical). From 2005 to 2009, he founded and was Chairman and Chief Executive Officer of Fovea Pharmaceuticals S.A., or Fovea, a privately funded biotech company, which was later acquired by Sanofi. He then became Senior Vice President of the Ophthalmology Division of Sanofi and served in that role until March 2012. Prior to Fovea, Dr. Gilly was a partner at Sofinnova Partners S.A.S. from December 2000 to November 2005. From January 1992 to October 2000, he was Chief Executive Officer of Transgene S.A., a company listed on the Nasdaq and the Nouveau Marche of Euronext Paris, France. Dr. Gilly received an engineering degree from Ecole Nationale d’Agronomie and a Ph.D. from Universite de Rennes. Profile
Word count: 2,220

TWST: So it’s been nearly four years since you last spoke with The Wall Street Transcript. Just as a refresher, can you talk about the focus of your company in the

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)
Interview with the Co-Founder and CEO: Equillium Inc. (NASDAQ:EQ)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Electric Cars and AI Fuel Long-Term Electricity Demand
Separating the Real Winners and Losers in the AI Boom
Generating Dividend Yield That’s Not Correlated to Interest Rates
ANALYST INTERVIEWS
Robust M&A Activity Provides Tailwind to Biotech Sector
Seeking Out Game Changers in Re-Emerging Biotech Sector
Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy